Dividends and Mixed Quarterly Results for Semiconductor Broad Line Companies - Research Report on Intel, Maxim Integrated, Freescale Semiconductor, Mellanox Technologies, and AFOP
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, July 31, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting Intel Corporation (NASDAQ: INTC), Maxim Integrated Products, Inc. (NASDAQ: MXIM), Freescale Semiconductor, Ltd. (NYSE: FSL), Mellanox Technologies, Ltd. (NASDAQ: MLNX), and Alliance Fiber Optic Products Inc. (NASDAQ: AFOP). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Intel Corporation Research Report
On July 25, 2013, Intel Corporation (Intel) announced that its Board of Directors has declared a quarterly dividend of $0.23 per share. Intel reported that the dividend is $0.90 per common share on an annual basis. The dividend is payable on September 1, 2013 to shareholders of record as of August 7, 2013. The Full Research Report on Intel Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/3f94_INTC]
Maxim Integrated Products, Inc. Research Report
On July 25, 2013, Maxim Integrated Products, Inc. (Maxim Integrated) released its Q4 FY 2013 and full-year FY 2013 financial results (period ended June 29, 2013). Revenues were up 0.5% YoY to $608.2 million in Q4 FY 2013 and up 1.6% YoY to $2.4 billion in full-year FY 2013. Net income was up 7.6% YoY to $119 million in Q4 FY 2013 and up 17.6% YoY to $454.9 million in full-year FY 2013. Diluted earnings per share were up 8.1% YoY to $0.40 in Q4 FY 2013 and up 17.8% YoY to $1.52 in full-year FY 2013. Tunc Doluca, President and CEO of Maxim Integrated commented, "We are disappointed by the weakness in end market demand for our smartphone products which resulted in revenue and earnings below expectations. This was partially offset by revenue growth in 22 of the 24 market segments that we address. We continue to generate strong profits and cash flow, and we are confident in our strategy and long-term business model as demonstrated by the increase in our dividend and share repurchases." The Full Research Report on Maxim Integrated Products, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/a8f1_MXIM]
Freescale Semiconductor, Ltd. Research Report
On July 25, 2013, Freescale Semiconductor, Ltd. (Freescale Semiconductor) released its Q2 FY 2013 financial results (period ended June 28, 2013). Net sales increased 0.9% YoY to $1.0 billion. Net loss was $65 million, compared to a net loss of $34 million in Q2 FY 2012. During the quarter, loss was $0.25 per diluted share, compared to a loss of $0.14 per diluted share in Q2 FY 2012. Gregg Lowe, President and CEO of Freescale Semiconductor, said, "Our overall financial results continued to improve both sequentially and year over year." Lowe continued, "Revenues, operating earnings and adjusted earnings per share all continued to grow and while we are still early into implementing our new strategy, we do see some signs of good progress." Freescale Semiconductor expects Q3 FY 2013 net sales to be in the range of $1.05 billion to $1.09 billion. It also expects gross margins to grow by approximately 75 to 100 basis points on a sequential basis. The Full Research Report on Freescale Semiconductor, Ltd. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/45b4_FSL]
Mellanox Technologies, Ltd. Research Report
On July 24, 2013, Mellanox Technologies, Ltd. (Mellanox Technologies) released its Q2 2013 financial results. Revenues were down 26.5% YoY to $98.2 million. Net loss was $1.7 million, or $0.04 per diluted share, compared to a net income of $32.1 million, or $0.74 per diluted share in Q2 2012. For H1 2013, revenues were down 18.4% YoY to $181.2 million. Net loss in H1 2013 was $10.2 million, or $ 0.24 per diluted share, compared to a net income of $44.5 million, or $1.04 per diluted share during H1 2012. Eyal Waldman, Mellanox Technologies President and CEO, stated, "We are pleased with our Q2 results. We see growth in the demand of our InfiniBand and Ethernet products. We increased our Ethernet top-of-rack switch system revenue by 81 percent sequentially, and, although off of a small base, we believe this indicates our growth opportunity once we have all the building blocks required for the various markets we serve." The Full Research Report on Mellanox Technologies, Ltd. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/42af_MLNX]
Alliance Fiber Optic Products Inc. Research Report
On July 23, 2013, Alliance Fiber Optic Products Inc. (AFOP) released its Q2 2013 financial results. Revenues were up 65.2% YoY to $19 million. Net income was up 247.6% YoY to $4.3 million. Diluted EPS was up 235.7% YoY to $0.47. For H1 2013, revenues were up 41.4% YoY to $31.2 million. Net income was up 184.8% YoY to $6.1 million, whereas diluted EPS was up 183.3% YoY to $0.68 during H1 2013. Peter Chang, President and CEO of AFOP, said, "We are very pleased with the exceptional financial performance and progress AFOP made in the quarter ended June 30, 2013. With excellent efforts by our Asia operations, we managed unexpected demand increases and delivered much higher than originally guided quarterly revenues. With our focus on operational excellence, we continued to improve gross margins to a record level above 38%, which resulted in a 132% increase in profits based on our 57% revenue growth from the previous quarter." The Full Research Report on Alliance Fiber Optic Products Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/22f0_AFOP]
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE Analysts' Corner
More by this Source
Global Cell Therapy - Technologies, Markets and Companies
Jan 16, 2014, 14:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.